Although the European Medicines Agency (EMA) recently approved a recombinant FVIIa (rFVIIa) for the treatment of acute bleeding in postpartum hemorrhage (PPH), its use is associated with risks of ...

A 33-year-old woman experienced a thunderclap headache immediately postpartum ... A subarachnoid hemorrhage was demonstrated on a head CT scan. Investigations. Physical examination, laboratory ...